web analytics
Pubblicità

di Giancarlo Nicoli

Feb

5

Bright Horizons For Dendreon

Filed Under Dendreon, Investimenti, SeekingAlpha Articles | Leave a Comment

My latest SeekingAlpha:

http://seekingalpha.com/article/1157741-bright-horizons-for-dendreon

Tags:

, , , , , , , , ,

di Giancarlo Nicoli

Jun

16

Dendreon Notable Links — For The Week Ending Friday, 22 June 2012

Filed Under Dendreon, Investimenti | Leave a Comment

Monday, 18 Kune 2012
Dr. Ryan Discusses Sequencing Prostate Cancer Therapies
http://www.onclive.com/onclive-tv/Dr-Ryan-Discusses-Sequencing-Prostate-Cancer-Therapies
Ryan views three distinct patient populations for each of the available treatments. He recommends that patients who are asymptomatic or indolent, who aren’t sick enough to receive chemotherapy, should be treated with sipuleucel-T.

Saturday, 16 June 2012
ASCO Update, Promising Treatment Sequences for Advanced Prostate Cancer
http://www.patientpower.info/video/asco-update-promising-treatment-sequences-for-advanced-prostate-cancer

 

@ @ @

DNDN website:
http://www.dendreon.com/

Provenge website:
http://provenge.com/

All links are verified and working at date of publication.

Tags:

, , , ,

di Giancarlo Nicoli

Jun

11

Dendreon Notable Links — For The Week Ending Friday, 15 June 2012

Filed Under Dendreon, Investimenti | Leave a Comment

Thursday, 14 June 2012
Four Later-Stage Immunotherapy Strategies Appear Promising
http://www.onclive.com/publications/Oncology-live/2012/May-2012/Four-Later-Stage-Immunotherapy-Strategies-Appear-Promising

Wednesday, 13 June 2012
Dendreon Shareholders Vent at Annual Meeting
http://www.xconomy.com/seattle/2012/06/13/dendreon-shareholders-vent-at-annual-meeting/

Wednesday, 13 June 2012
Dendreon shareholders complain about stock losses
http://seattletimes.nwsource.com/html/businesstechnology/2018421846_dendreon14.html

Wednesday, 13 June 2012
Summer Street starts Dendreon with buy
http://www.investorvillage.com/smbd.asp?mb=971&mn=440451&pt=msg&mid=11818750

Tuesday, 12 June 2012
Provenge vs Zytiga for Prostate Cancer: What You Should Know
http://www.prostate.net/2012/prostate-cancer/provenge-vs-zytiga-what-you-should-know/

Tuesday, 12 June 2012
Zytiga plus Provenge could become SOC in chemo-naïve metastatic prostate cancer
http://www.biocentury.com/biotech-pharma-news/coverstory/2012-06-11/
zytiga-plus-provenge-could-become-soc-in-chemo-nave-metastatic-prostate-cancer-a1

Monday, 11 June 2012
Miller on the Burrill Report (June 11, 2012): Why Dendreon May Have Felt Less Pain at ASCO than Expected (.MP3,16.21 Mb) (It’s an audio podcast)
http://www.burrillreport.com/content/podcast/CUT_SPM_BRP-6-11-12.mp3

Monday, 11 June 2012
Provider update from yahoo
http://www.investorvillage.com/smbd.asp?mb=971&mn=440240&pt=msg&mid=11809917

 

@ @ @

DNDN website:
http://www.dendreon.com/

Provenge website:
http://provenge.com/

All links are verified and working at date of publication.

Tags:

, , , ,

di Giancarlo Nicoli

Jun

7

Provenge Has A Bigger Market Than You Think

Filed Under Dendreon, Investimenti, SeekingAlpha Articles | Leave a Comment

My latest Seeking Alpha:

http://seekingalpha.com/article/643181-provenge-has-a-bigger-market-than-you-think

Tags:

, , , , , , ,

di Giancarlo Nicoli

Jun

4

Dendreon Notable Links — For The Week Ending Friday, 8 June 2012

Filed Under Dendreon, Investimenti | Leave a Comment

Thursday, 7 June 2012
Provenge Has A Bigger Market Than You Think
http://seekingalpha.com/article/643181-provenge-has-a-bigger-market-than-you-think

Monday, 4 June 2012
Dendreon slide seen coming to an end
http://finance.yahoo.com/news/dendreon-slide-seen-coming-end-151958149.html
A trader sold 3,555 July 6 puts for the bid price of $0.60

Monday, 4 June 2012
Johnson & Johnson’s Prostate Drug Fails Clinical Trial
http://www.minyanville.com/sectors/biotech-pharma/articles/
jnj-johnson-and-johnson-cancer-drugs/6/4/2012/id/41448

Monday, 4 June 2012
Ocyan on ’302′…

http://www.investorvillage.com/smbd.asp?mb=971&mn=439538&pt=msg&mid=11789245

Monday, 4 June 2012
Johnson & Johnson’s Zytiga Data Argue For Sequencing Dendreon’s Provenge First
http://seekingalpha.com/article/634551-
johnson-johnson-s-zytiga-data-argue-for-sequencing-dendreon-s-provenge-first

@ @ @

DNDN website:
http://www.dendreon.com/

Provenge website:
http://provenge.com/

All links are verified and working at date of publication.

Tags:

, , , , ,

di Giancarlo Nicoli

May

26

Dendreon Notable Links — For The Week Ending Friday, 1 June 2012

Filed Under Dendreon, Investimenti | Leave a Comment

Friday, 01 June 2012
Las Cruces Sun News – New prostate cancer treatment takes a targeted approach
http://www.lcsun-news.com/las_cruces-healthy_u/ci_20757229/
new-prostate-cancer-treatment-takes-targeted-approach

Friday, 01 June 2012
Georgia Health Sciences Health System – Advanced Prostate Cancer: Provenge® immunotherapy
http://www.mcghealth.org/e-news/GhsuContentPage.aspx?nd=3139

Wednesday, 30 May 2012
At the AUA Meeting – Does Provenge Provide Better Survival Numbers?
http://advancedprostatecancer.net/?p=3251

Tuesday, 29 May 2012
Provenge – A Patient’s Perspective
http://www.prostate-cancer.org/pcricms/sites/default/files
/PDFs/November%202011%20PCRI%20Insights%20-%20Provenge%20-%20A%20Patient%27s%20Perspective.pdf

Saturday, 26 May 2012
Back into Dendreon
http://mindonmoney.wordpress.com/2012/05/25/back-into-dendreon/

Saturday, 26 May 2012
Rallying around the dads
http://heraldnews.suntimes.com/lifestyles/12572272-423/rallying-around-the-dads.html

Saturday, 26 May 2012
Dendreon Announces Webcast Presentations at Upcoming Conferences
http://investor.dendreon.com/releasedetail.cfm?ReleaseID=677165

 

@ @ @

DNDN website:
http://www.dendreon.com/

Provenge website:
http://provenge.com/

All links are verified and working at date of publication.

Tags:

, , , ,

di Giancarlo Nicoli

May

21

Dendreon Notable Links — For The Week Ending Friday, 25 May 2012.

Filed Under Dendreon, Investimenti | Leave a Comment

Monday, 21 May 2012
AUA – by BSR David
http://www.investorvillage.com/smbd.asp?mb=971&mn=438418&pt=msg&mid=11748571

Monday, 21 May 2012
Dendreon Announces Data Presentation at the 2012 American Urological Association Annual Meeting
http://investor.dendreon.com/releasedetail.cfm?ReleaseID=675334

Monday, 21 May 2012
What You Must Know Before Investing in Prostate Cancer Stocks (Part One)
http://www.minyanville.com/business-news/editors-pick/articles/
cancer-stocks-prostate-cancer-stocks-biotech/5/21/2012/id/41132

Saturday, 19 May 2012
Sequencing Prostate Cancer Treatments
http://www.investorvillage.com/smbd.asp?mb=971&mn=438262&pt=msg&mid=11744370

@ @ @

DNDN website:
http://www.dendreon.com/

Provenge website:
http://provenge.com/

All links are verified and working at date of publication.

Tags:

, , , ,

Next Page →